Affinivax's Series A - II Round

Affinivax raised a round of funding on February 05, 2016. Investors include Bill & Melinda Gates Foundation.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious disease…

Articles about Affinivax's Series A - II Round: